Anti-TNFRSF17/BCMA/CD269 Antibody (Belantamab)
Catalog No.
F1045
Anti-TNFRSF17/BCMA/CD269 Antibody (Belantamab)
Featured Products
Belantamab (GSK2857914) is a humanized IgG1 anti-BCMA (TNFRSF17) monoclonal antibody. Belantamab can be used to synthesize antibody-active molecule conjugates (ADCs), Belantamab mafodotin.
Quality Control & DataSheet
- View current batch:
-
Purity > 95% by SDS-PAGE and SEC-HPLC analyses.
- COA (Certificate Of Analysis)
- MSDS (Material Safety Data Sheet)
- Datasheet
146.06 kDa
Dry ice
2061894-48-0
-80°C
2 years
Liquid
See label
For reconstitution, we recommend adding sterile, distilled water to achieve a final antibody concentration. Gently shake it to solubilize the protein completely. Do not vortex.
CHO
Bela, GSK-2857914, J6M0
100 mM Pro 20 mM Arg pH 5.0. No preservative!
Q02223
Human, Mouse
Unconjugated
Monoclonal
Protein A
IgG1
ELISA, FACS, Kinetics, Functional assay, Animal Model
U266 cells were stained with Anti-TNFRSF17/BCMA/CD269 Antibody (Belantamab) and negative control protein respectively, washed and then followed by PE and analyzed with FACS
TNFRSF17 / BCMA / CD269
Please avoid freeze-thaw cycles.